Company intelligence / Profile preview

山东青佰欣达医药科技

Jinan, Shandong, China

Ownership: Private
Development stage: Other

Overview

Shandong Qingbai Xinda Pharmaceutical Technology is a China-based pharmaceutical technology company specializing in the research, development, and technical transfer of chemical drugs and pharmaceutical intermediates. The company provides contract research organization (CRO) services, focusing on the synthesis of high-end generic drugs and innovative small molecule compounds. Its business scope includes the development of pharmaceutical production processes, quality control standards, and regulatory filing support for the domestic Chinese market. The firm operates primarily as a technical service provider for larger pharmaceutical manufacturers seeking to optimize their chemical synthesis and drug formulation pipelines.

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on 山东青佰欣达医药科技.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 山东青佰欣达医药科技.

Explore the full profile